EC50 and Hill Slope Calculator for Agonist Responses
Compare two synthetic rising concentration-response curves using the same four-parameter model. The reference pairs a Hill +1 design with a Hill +2 design and preserves their different plateaus and concentration ranges. An empirical slope describes response steepness here; it is not automatically a molecular cooperativity coefficient.
C19 contains ten concentrations in triplicate; C20 contains ten in duplicate. Both originate in the independently generated synthetic-curve set. Their generating midpoint and plateau values also differ, so the pair is not a controlled experiment changing slope alone.
Name the endpoint before interpreting the midpoint
An activation assay may measure second messenger, reporter output, phosphorylation or another downstream response. The concentration that reaches the midpoint of that readout depends on the entire experimental system. State which endpoint is being fitted and whether the response was normalised to vehicle, an external agonist or each curve’s own range. Those choices affect what an EC50 comparison means.
The reference curves deliberately retain their original scales. Look at the raw points and fitted plateaus before comparing slope. A curve with a higher maximum can look steeper on a shared absolute axis even when its fractional transition is similar. Conversely, independently scaling each curve to zero and one hundred can conceal a real difference in maximal response.
Use the Hill parameter as a descriptive quantity
The fitted Hill parameter determines how rapidly the response changes around the relative midpoint on a logarithmic concentration axis. It is useful for identifying poorly covered transitions and unusual shapes. Its numerical value is sensitive to the tested concentration spacing, plateau constraints and noise. A coarse series may provide little information about a very steep transition, even if the optimiser returns a finite slope.
When comparing agonists, preserve experimental run identity and show uncertainty rather than ranking compounds on point estimates alone. Partial agonism, desensitisation or toxicity can make a simple rising sigmoid inappropriate. A response that turns down at the highest doses belongs in a separate shape review. Keep the model choice explicit and avoid converting a fitted EC50 into an equilibrium dissociation constant without additional assumptions and measurements.
Equations and variables
Four-parameter logistic response
y = B + (T − B) / [1 + 10^((m − x)h)]
- y
- Expected response (response units)
- B, T
- Lower and upper response asymptotes (response units)
- x
- Base-10 logarithm of concentration in mol/L
- m
- Base-10 logarithm of the relative midpoint in mol/L
- h
- Signed Hill slope; positive for activation, negative for inhibition
Relative activation midpoint
EC50 = 10ᵐ mol/L; y(EC50) = (T + B)/2
- EC50
- Concentration halfway between the fitted response asymptotes (mol/L)
- m
- Base-10 logarithm of the midpoint concentration
- T, B
- Fitted upper and lower response asymptotes
Scope and limitations
- A positive Hill slope represents a rising curve in this implementation. Sign conventions differ across software.
- Relative EC50 is defined by the fitted span, not necessarily half the response of an external full-agonist control.
- Receptor reserve, signal amplification, heterogeneous populations and assay timing can affect an empirical slope and midpoint. These fits do not distinguish those mechanisms.
Sources and provenance
- Synthetic curves C03, C19 and C20 with independent R referencesMIT; original generated data
Inputs generated outside the fitted TypeScript implementation; historical expected outputs must be read with their method version.
- Published numerical verification inputs and independent referencesOriginal synthetic inputs; see individual fixture notices
The generated inputs are demonstrations, not experimental measurements. Existing versioned fixtures are retained unchanged.
- Black and Leff: operational models of pharmacological agonismArticle citation; no reproduced data
Background for distinguishing observed response from affinity and efficacy; this route opens the empirical 4PL fit.
Technical questions
Does a Hill slope above one prove cooperativity?
No. The fitted response curve can be steepened by biological signalling, heterogeneous exposure, assay design or other mechanisms. A mechanistic cooperativity claim needs an appropriate binding or response model and evidence beyond this empirical four-parameter curve.
Can I compare these EC50 values directly?
The synthetic values illustrate fitting. For experimental comparison, match the system, exposure, readout and response definition, and inspect both curves for coverage and uncertainty. A shift in EC50 does not by itself establish a shift in binding affinity.
Why are the two maximal responses different?
The inputs were generated with different upper and lower plateaus as well as different slopes and midpoints. Keeping that distinction visible prevents the example being read as a single-factor cooperativity experiment. The live tool fits each supplied series from its own observations.
Connected workflows
- 4PL IC50 curve fitting
Compare midpoint definitions and plateau diagnostics.
- Bell-shaped dose-response analysis
Investigate activation that falls at higher concentrations.
- EGFR sequence and structure inspection
Keep target annotations distinct from fitted response parameters.
- Michaelis-Menten Km and Vmax Nonlinear Kinetics Fitter
Contrast an empirical sigmoid with the hyperbolic Michaelis-Menten fit of initial rates.
- Thermal Shift DSF Melt Curve and Boltzmann Apparent Tm
Fit a rising sigmoid of a different kind: a protein melt curve for apparent Tm.
- OD600 Growth Rate, Doubling Time and Gompertz Curve Fitter
Move from dose-response sigmoids to microbial growth curves and the modified Gompertz fit.